Evidence is mounting on the undertreatment of women with cardiovascular disease. Women face delays in recognition of disease and compared to men are less likely to receive guideline-directed medical therapy or the right intensification of therapy. Explore how CVD presents differently in women and how to tailor treatment strategies based on physiological differences to optimize patient outcomes. This course will dig into sex-based gaps and optimization of treatment in atrial fibrillation, coronary heart disease, and heart failure.
We are grateful to these distinguished Members of the American College of Cardiology who contributed to this collection:
Noel Bairey Merz, MD, FACCMartha Gulati, MD, FACC Jennifer H. Mieres, MD, FACC